Cindy Ippoliti

Statistics

Publications

Citations

5.5K

H-Index

Active since

1993

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Cornell University

The University of Texas Health Science Center at Houston

Baylor College of Medicine

NewYork–Presbyterian Hospital

Cindy Ippoliti is an author at The University of Texas MD Anderson Cancer Center specializing in transplant immunology, stem cell transplantation, and medicine.

Publications per year

1993–2018

Publications

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling et al. · Journal of Clinical Oncology · 1998 · 927 citations

Medicine, Immunology, Oncology +17

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

Marcos de Lima, Mark F. Munsell, Munir Shahjahan et al. · Blood · 2004 · 373 citations · Full text

Medicine, Hematology, Oncology +16

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Issa F. Khouri, Rima M. Saliba, Sergio Giralt et al. · Blood · 2001 · 363 citations

Life Sciences, Hematology, Immunology +14

Tumor necrosis factor-α blockade for the treatment of acute GVHD

Daniel R. Couriel, Rima M. Saliba, Krystal Hicks et al. · Blood · 2004 · 261 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +7

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti et al. · Blood · 2000 · 240 citations

Life Sciences, Immunology, Pharmacotherapy +11

1–5 of 57